Dr. Muzammil Shaikh is a renowned medical oncologist with over 20 years of extensive clinical, academic, and research experience in oncology. He has served at leading cancer institutions in India such as Gujarat Cancer & Research Institute, P.D. Hinduja National Hospital, and now at Nanavati Max Hospital. His training includes a prestigious observership at M.D. Anderson Cancer Center, Houston, USA. Dr. Shaikh has contributed to several national and international publications and is also a Gold Medalist in Medical Oncology. Known for his patient-centric approach, he combines evidence-based medicine with compassionate care.
Educational Qualifications:
- MBBS – Grant Medical College & Sir J.J. Hospital, Mumbai (2001)
- MD (Internal Medicine) – Seth G.S. Medical College & KEM Hospital, Mumbai (2006)
- DM (Medical Oncology) – Gujarat Cancer & Research Institute (2010)
- DNB (Medical Oncology) – National Board of Examinations, New Delhi (2011)
- Observership – M.D. Anderson Cancer Centre, Houston, USA (2013)
Professional Experience:
- Dr. Muzammil Shaikh is currently working at Max Healthcare
- More than 20 years experience
- May 2013 – June 2013 Observership in M.D. Anderson Cancer Centre, Houston, Texas, USA
- April 2013 till date Consultant Medical Oncologist, P.D. Hinduja National Hospital & MRC, Mumbai
- May 2012 – March 2013 Jr. Consultant, P.D. Hinduja National Hospital & Medical Research Centre, Mumbai
- Sept 2010 – May 2012 Associate Consultant, P.D. Hinduja National Hospital & Medical Research Centre, Mumbai
- Aug 2007 – July 2010 Senior Registrar, The Gujarat Cancer & Research Institute & Cancer Center, Gujarat
Professional Memberships:
- Indian Co-operative Oncology Network (ICON)
- Indian Musculo Skeletal Oncology Study Group (IMSOS)
- European Society of Medical Oncology (ESMO)
- Mumbai Hematology Group (MHG)
- Indian Medical Association (IMA)
Research Papers & Publications:
- Gold Medal in Medical Oncology at Gujarat University
- Chemotherapy in Osteosarcoma. Dr Shaikh Muzammil, Dr Asha Kapadia, Dr Sachin Almel;pgs 93-108 in textbook on osteosarcoma by INTECH publications. E book site : Website: http://www.intechopen.com. April 2012.
- Tumor markers in gynecological malignancies. Dr Shaikh Muzammil, Dr Asha Kapadia. Current Opinion in Obstetrics & Gynecology -2012” (In publication by Jaypee India) July 2012.
- Breast – Prevalence, Screening, Risk factors, Prevention, Effect of HT". Dr Shaikh Muzammil, Dr Asha Kapadia. Clinical Practice Guidelines on Menopause (In press). July 2012.
- Hormone replacement therapy in breast cancer, Dr Asha Kapadia, Dr Shaikh Muzammil. 11th World Congress & 19th Indian Conference on “Reproductive & Child Health” September 2012.
- Treatment outcome for Germ cell tumour brain:Experience from a single centre.
- V Kanan,B K Misra,A Kapadia,A sachin,M.ShaikhR. Bajpai,V AnandS.Deshpande,M sankhe,K Desai,Aarthi K,Hinduja hospital,Mumbai
- GC – 001. Treatment outcome for Germ cell Tumor (GCT) Brain: Experience from a Single Centre. V Kanan, B.K. Misra,A Kapadia, Dr. Sachin Almel, Dr Muzammil Shaikh, Dr Milind Sankhe, Dr Ketan Desai, Dr Vivek Anand, Dr Aarthi Kannan, Hinduja hospital, Mumbai
- A Single-Institution Retrospective Analysis of Outcomes for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy Kannan Venkatesan, Vivek Anand, Ranjeet Bajpai, Rohit Santosh Kabre, Asha Kapadia, Sachin Almel, Muzammil Shaikh, Vinay Babu, Ajay Kolse, Ganesh Nagrajan, Murad Lala, Smruti krishna, P Jagannath, Sudesh Deshpande
.png)
.png)
.png)